Small Molecules, Biologics, Orphan Drugs
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
60
NCT06095713
German Observational Multicenter Study of Patients With Fabry Disease Under Enzyme Replacement Therapy With Pegunigalsidase-alfa
Phase: N/A
Role: Collaborator
Start: Oct 1, 2023
Completion: Sep 30, 2027
Loading map...